Condition: Antibody-mediated Rejection in Kidney Transplant · Sponsor: Centre Hospitalier Universitaire de Besancon
This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
This description comes directly from the study's public registry record.
Charline Vauchy, PhD. · +33381218875 · cvauchy@chu-besancon.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire de Besançon | Besançon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07663669